Results 101 to 110 of about 11,231 (185)

Antifungal effects of echinocandins diminish when exposed to intestinal lumen contents: a finding with potentially significant clinical implications

open access: yesFrontiers in Pharmacology
Echinocandins, a prominent class of antifungals, are known for their broad-spectrum activity and favorable safety profiles. However, their bioavailability and efficacy via oral route are suboptimal. In this study, caspofungin and micafungin, the two most
Sepideh Mehravar   +5 more
doaj   +1 more source

Osmo-remedial phenotype of micafungin-sensitive mutants.

open access: yes, 2013
Wild-type cells and micafungin-sensitive mutants grown at log phase were spotted onto each plate as indicated and then incubated at 27°C for 4 days.
Yuki Yamada (104430)   +6 more
core   +1 more source

Plasma Concentration of Antifungal Agent Micafungin for Pediatric Living Donor Liver Transplantation [PDF]

open access: yes
Ueno T., Takase K., Deguchi K., et al. Plasma Concentration of Antifungal Agent Micafungin for Pediatric Living Donor Liver Transplantation. Transplantation Proceedings 56, 602 (2024); https://doi.org/10.1016/j.transproceed.2024.01.020.Background ...
Takase, Koki   +8 more
core   +1 more source

Micafungin as primary antifungal prophylaxis in patients presenting withacute myeloid leukemia

open access: yes, 2016
International audienceObjective. – To study the efficacy and safety of micafungin for prophylaxis of invasive fungal infections in patients undergoing inductionchemotherapy for acute myeloid leukemia.Patients and methods.
Labiad, Yasmine   +9 more
core   +1 more source

Perspectives on the Use of Echinocandins in the Neonatal Intensive Care Unit

open access: yesAntibiotics
The neonatal intensive care unit (NICU) population, especially low birth weight and critically ill neonates, is at risk of invasive Candida infections, which are associated with high mortality rates and unfavorable long-term outcomes.
Niki Dermitzaki   +5 more
doaj   +1 more source

"De-escalation" strategy using micafungin for the treatment of systemic Candida infections: budget impact in France and Germany

open access: yes, 2017
Anke van Engen,1 Montserrat Casamayor,2 Soyoung Kim,3 Maureen Watt,4 Isaac Odeyemi4 1Quintiles Consulting, Hoofddorp, the Netherlands; 2Quintiles Consulting, Barcelona, Spain; 3Astellas Pharma Singapore Pte., Singapore; 4Astellas Pharma Inc., Chertsey ...
Casamayor M   +4 more
core  

Evaluation of Micafungin Use in Children

open access: yes
Micafungin is recommended especially in patients with liver and kidney failure and in the presence of other side effects due to antifungals apart from its known priority indications such as invasive candidiasis.
Sevinir, B   +14 more
core  

Home - About - Disclaimer - Privacy